Literature DB >> 8369593

The problems of anticholinergic adverse effects in older patients.

M Feinberg1.   

Abstract

The old saying 'red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter' is often quoted when describing the autonomic effects of drugs that block the muscarinic cholinergic system. These effects may be subtle or dramatic, yet can be overlooked or discounted as a natural consequence of old age. Elderly patients can be particularly sensitive to the anticholinergic action of drugs because of physiological and pathophysiological changes that often accompany the aging process. The use of multiple drugs, a common finding in older patients, may result in pharmacodynamic and pharmacokinetic drug interactions that heighten anticholinergic effects. While the classic anticholinergic problems of decreased secretions, slowed gastrointestinal motility, blurred vision, increased heart rate, heat intolerance, sedation and possibly mild confusion, may be uncomfortable for a younger patient in relatively good health, these effects can be disastrous for older patients. Even the most common peripheral anticholinergic complaint of dry mouth can reduce the ability to communicate, predispose to malnutrition, promote mucosal damage, denture misfit or dental caries, and increase the risk of serious respiratory infection secondary to loss of antimicrobial activity of saliva. Mydriasis and the inability to accommodate will impair near vision and may precipitate narrow angle glaucoma in predisposed patients, but less obviously could lead to an increased risk of accidents, including falls. Somatic complaints of constipation and urinary hesitancy, could, in the presence of anticholinergic challenge, result in faecal impaction or urinary retention. Cardiac effects may be poorly tolerated. Increases in heart rate may precipitate or worsen angina. Finally, thermoregulatory impairment induced by anticholinergics, which block the ability to sweat, may lead to life threatening hyperthermia. Central anticholinergic effects range from sedation, mild confusion and inability to concentration to frank delirium. Even mild effects can reduce function and increase dependency. At any level of care, the loss of independence increases the caregiver burden, costs, and most importantly, can negatively affect quality of life. Many age-related and disease-related conditions may predispose elderly patients to anticholinergic drug toxicity. Careful attention to anticholinergic effects when prescribing drugs, patient education, regular review of the entire drug regimen, and familiarity with the signs and symptoms of anticholinergic toxicity will help to reduce the risk of drug-induced problems.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8369593     DOI: 10.2165/00002512-199303040-00004

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  57 in total

1.  Health hazards of unusual herbal teas.

Authors:  P M Ridker
Journal:  Am Fam Physician       Date:  1989-05       Impact factor: 3.292

2.  Nonprescription drugs and the elderly.

Authors:  P P Lamy
Journal:  Am Fam Physician       Date:  1989-06       Impact factor: 3.292

3.  Oxybutynin: is it safe?

Authors:  R J Baigrie; J P Kelleher; D P Fawcett; A W Pengelly
Journal:  Br J Urol       Date:  1988-10

4.  Prescribing in old age.

Authors:  C G Swift
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

5.  Xerostomia: not a phenomenon of aging.

Authors:  P M Lloyd
Journal:  Wis Med J       Date:  1983-09

6.  Absorption of antibiotics: influence of metoclopramide and atropine on serum levels of pivampicillin and tetracycline.

Authors:  G Gothoni; P Pentikäinen; H I Vapaatalo; R Hackman; K af Björksten
Journal:  Ann Clin Res       Date:  1972-08

7.  Terodiline causes polymorphic ventricular tachycardia due to reduced heart rate and prolongation of QT interval.

Authors:  D A Stewart; J Taylor; S Ghosh; G J Macphee; I Abdullah; J M McLenachan; D J Stott
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Amitriptyline selectively disrupts verbal recall from secondary memory of the normal aged.

Authors:  R J Branconnier; D R DeVitt; J O Cole; K F Spera
Journal:  Neurobiol Aging       Date:  1982       Impact factor: 4.673

9.  Self-poisoning with over-the-counter hypnotics.

Authors:  M D Allen; D J Greenblatt; B J Noel
Journal:  Clin Toxicol       Date:  1979       Impact factor: 4.467

10.  Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.

Authors:  T Sunderland; P N Tariot; R M Cohen; H Weingartner; E A Mueller; D L Murphy
Journal:  Arch Gen Psychiatry       Date:  1987-05
View more
  77 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

Review 2.  Overcoming gaps in the management of chronic obstructive pulmonary disease in older patients: new insights.

Authors:  Jacob Gelberg; R Andrew McIvor
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

3.  [Pharmacotherapy of elderly patients from the clinical viewpoint].

Authors:  H Burkhardt; R Gladisch
Journal:  Internist (Berl)       Date:  2003-08       Impact factor: 0.743

Review 4.  An approach to drug induced delirium in the elderly.

Authors:  K Alagiakrishnan; C A Wiens
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

5.  Urodynamics in the octogenarian female: is it worthwhile?

Authors:  Stephen J Bromage; Trevor J Dorkin; Lewis Chan; Vincent Tse
Journal:  Int Urogynecol J       Date:  2010-06-15       Impact factor: 2.894

6.  Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.

Authors:  Satabdi Chatterjee; Sandhya Mehta; Jeffrey T Sherer; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2010-12-01       Impact factor: 3.923

Review 7.  Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.

Authors:  Michael G Oefelein
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

8.  Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.

Authors:  Sunil Swami; Ronald A Cohen; John A Kairalla; Todd M Manini
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

Review 9.  Identification and management of in-hospital drug-induced delirium in older patients.

Authors:  Angela G Catic
Journal:  Drugs Aging       Date:  2011-09-01       Impact factor: 3.923

Review 10.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.